Clinical Trial

CPT-fMRI Study for PTSD

Study Description

CPT-fMRI Study for PTSD

Posttraumatic stress disorder (PTSD) is prevalent mental illness (~9% life-time) that results from exposure to trauma. As it is associated with vastly heterogeneous origins, accurate diagnosis and optimal treatment strategies are sometimes very difficult to achieve. No known biomarker exists, which makes it difficult to assess treatment response and functional outcomes. The recent brain imaging studies have suggested that PTSD patients show abnormal brain connectivity measured by functional magnetic resonance imaging (fMRI). The investigators propose that cognitive processing therapy may ameliorate this functional connectivity abnormality which may be related with their symptomatic improvement.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Behavioral - cognitive processing therapy

Group therapy for PTSD patients

Additional Information

Official Study Title

Identification of Neuroimaging-Based Biomarkers in the Treatment of Posttraumatic Stress Disorder

Clinical Trial ID

NCT03229915

ParticipAid ID

vbmp0a